Jan 31 (Reuters) - Cytosorbents Corp CTSO.O :
* CYTOSORBENTS ISSUES STOCKHOLDER LETTER AND REPORTS
PRELIMINARY
FOURTH QUARTER AND FULL YEAR 2022 REVENUE
* CYTOSORBENTS CORP - Q4 2022 PRODUCT SALES REBOUNDED FROM
Q3 2022
LOW
* CYTOSORBENTS CORP - ADJUSTED FOR CONSTANT CURRENCY, CORE
NON-COVID 2022 PRODUCT SALES WERE WITHIN 5% OF THAT ACHIEVED IN
2021
* CYTOSORBENTS CORP - Q4 2022 TOTAL REVENUE WAS
APPROXIMATELY $9.4
MILLION VERSUS $10.8 MILLION IN Q4 2021
Source text for Eikon: ID:nPn3bmzSMa
Further company coverage: CTSO.O
((Reuters.Briefs@thomsonreuters.com;))